Atlas Trials

Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma

Clinical trial NCT06924424 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06924424
Sponsor
Peking University People's Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiple Myeloma, Neoplasms
Start date
2025-03-01
Primary completion
2026-12-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.